Items where Author is "KHEONG, CHAN WAH"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article | Other
Number of items: 35.

Article

KHEONG, CHAN WAH (2015) A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatology International, 9 (4). pp. 594-602.

KHEONG, CHAN WAH (2015) Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non- alcoholic fatty liver disease. Scientific Reports, 5. p. 13306.

KHEONG, CHAN WAH (2015) Low physical activity and energy dense Malaysian foods are associated with non- alcoholic fatty liver disease in centrally obese but not in non-centrally obese patients with diabetes mellitus. Asia Pacific Journal of Clinical Nutrition, 24 (2). pp. 289-98.

KHEONG, CHAN WAH (2015) Low physical activity and energy dense Malaysian foods are associated with non- alcoholic fatty liver dis-ease in centrally obese but not in non-centrally obese patients with diabetes mellitus. Asia Pac J Clin Nutr, 24 (2). pp. 289-98.

KHEONG, CHAN WAH (2015) Narrow-band imaging and white-light endoscopy with optical magnification in the diagnosis of dysplasia in Barrett s esophagus: results of the Asia-Pacific Barrett s Consortium. Endoscopy International Open, 3 (1). E14-8.

KHEONG, CHAN WAH (2015) Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy. Journal of Digestive Diseases, 16 (9). pp. 537-40.

KHEONG, CHAN WAH (2014) Controlled attenuation parameter for detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease. pp. 1470-6.

KHEONG, CHAN WAH (2014) Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Plos One.

KHEONG, CHAN WAH (2014) Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males. Hepatology International, 8 (1). pp. 121-7.

KHEONG, CHAN WAH (2014) Progression of non-alcoholic fatty liver disease a prospective clinicopathological follow-up study. Journal of Digestive Diseases, 15 (10). pp. 545-52.

KHEONG, CHAN WAH (2014) Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy. World Journal of Gastroenterology.

KHEONG, CHAN WAH (2014) Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clinics and Research in Hepatology and Gastroenterology, 38 (3). pp. 284-91.

KHEONG, CHAN WAH (2013) Epidemiology of a Fast-Emerging Disease in the Asia Pacific Region - Non-Alcoholic Fatty Liver Disease (NAFLD). Hepatology International, 7 (1). pp. 65-71.

Other

KHEONG, CHAN WAH (2015) A novel 2 step approach combining the nafld fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Springer.

KHEONG, CHAN WAH (2015) Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? Wiley.

KHEONG, CHAN WAH (2015) Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease? Malaysian Society of Gastroenterology and Hepatology.

KHEONG, CHAN WAH (2015) Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Springer.

KHEONG, CHAN WAH (2015) Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. Wiley.

KHEONG, CHAN WAH (2015) Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind placebo-controlled trial. EMJ.

KHEONG, CHAN WAH (2015) Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. Elsevier.

KHEONG, CHAN WAH (2015) Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial. Malaysian Society of Gastroenterology and Hepatology.

KHEONG, CHAN WAH (2014) Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease. Wiley-Blackwell.

KHEONG, CHAN WAH (2014) Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non- alcoholic fatty liver disease. Malaysian Society of Gastroenterology and Hepatology.

KHEONG, CHAN WAH (2014) Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease. Malaysian Society of Gastroenterology and Hepatology.

KHEONG, CHAN WAH (2014) Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease. Springer.

KHEONG, CHAN WAH (2014) Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Wiley-Blackwell.

KHEONG, CHAN WAH (2014) Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers. Malaysian Society of Gastroenterology and Hepatology.

KHEONG, CHAN WAH (2013) Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics. UNSPECIFIED.

KHEONG, CHAN WAH (2013) Non-alcoholic fatty liver disease in young adults  worrying ethnic differences in a multi-racial Asian population in Malaysia. UNSPECIFIED.

KHEONG, CHAN WAH (2013) Prevalence of NAFLD and associated factors among multi- racial Malaysian population. Wiley Blackwell.

KHEONG, CHAN WAH (2013) Progression of non-alcoholic fatty liver disease (NAFLD)  a prospective clinicopathological follow-up study. UNSPECIFIED.

KHEONG, CHAN WAH (2013) Reduced-volume PEG-ELS plus bisacodyl split- dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study. UNSPECIFIED.

KHEONG, CHAN WAH (2013) Split versus whole-dose PEG-ELS for bowel preparation in outpatient colonoscopy. Wiley Blackwell.

KHEONG, CHAN WAH (2013) Ultrasonography-diagnosed NAFLD is not associated with IHD among long-standing poorly-controlled diabetics. Wiley Blackwell.

KHEONG, CHAN WAH (2013) Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long-standing poorly controlled diabetics. UNSPECIFIED.

This list was generated on Sat Nov 25 01:58:06 2017 MYT.